BeStock  
Stocks › Drug Manufacturers - Specialty & Generic › XERS

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2842Drug Manufacturers - Specialty & Generic
$10.13 +$1.05 (+11.56%)
Pre-market · Oct 6, 5:10 am ET · After hours $10.11 -0.20%
Open$9.15
Prev close$9.08
Day range$9.12 – $10.24
Volume4.66M
Market cap$1.85B
P/E (TTM)–
Dividend yield–

XERS Stock News

Headlines matching Xeris Pharmaceuticals or the XERS ticker, most recent first.

  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $12Market news · 29 Sep 2026
  • H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)TipRanks · 22 Sep 2026
  • H.C. Wainwright Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $10Market news · 22 Sep 2026
  • Piper Sandler Maintains Xeris Pharmaceuticals(XERS.US) With Hold Rating, Maintains Target Price $8Market news · 10 Sep 2026
  • Leerink Partners Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $16Market news · 10 Sep 2026
  • Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $12Market news · 20 Aug 2026
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $12Market news · 8 Jul 2026
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy RatingMarket news · 1 Jul 2026
  • Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $9Market news · 14 May 2026
  • Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Xeris Pharmaceuticals (XERS)TipRanks · 3 Mar 2026
  • Xeris Pharmaceuticals (XERS) Receives a Buy From H.C. WainwrightTipRanks · 17 Sep 2025
  • Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $11Market news · 8 Aug 2025
  • Oppenheimer Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $8Market news · 8 Aug 2025
  • Leerink Partners Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $9Market news · 20 Aug 2025
  • TR | OpenAI - 4o Maintains Xeris Pharmaceuticals(XERS.US) With Hold Rating, Raises Target Price to $7.5Market news · 12 Aug 2025

Discussion

No comments yet — be the first to weigh in on XERS.

Leave a comment

Scroll to Top